Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors

Biomedicines. 2022 Oct 3;10(10):2475. doi: 10.3390/biomedicines10102475.

Abstract

Seizures are one of the most common symptoms of brain tumors. The incidence of seizures differs among brain tumor type, grade, location and size, but paediatric-type diffuse low-grade gliomas/glioneuronal tumors are often highly epileptogenic. The extracellular matrix (ECM) is known to play a role in epileptogenesis and tumorigenesis because it is involved in the (re)modelling of neuronal connections and cell-cell signaling. In this review, we discuss the epileptogenicity of brain tumors with a focus on tumor type, location, genetics and the role of the extracellular matrix. In addition to functional problems, epileptogenic tumors can lead to increased morbidity and mortality, stigmatization and life-long care. The health advantages can be major if the epileptogenic properties of brain tumors are better understood. Surgical resection is the most common treatment of epilepsy-associated tumors, but post-surgery seizure-freedom is not always achieved. Therefore, we also discuss potential novel therapies aiming to restore ECM function.

Keywords: brain tumor; epileptogenesis; extracellular matrix; low-grade epilepsy-associated neuroepithelial tumors; low-grade gliomas; matrix metalloproteinases.

Publication types

  • Review